Design and Evaluation of a Systemically Active Agent, Fluconazole-Reference-Cited by-同舟云学术

Design and Evaluation of a Systemically Active Agent, Fluconazole

Published:1988-12 Issue:1 Antifungal Dr Volume:544 Page:4-11
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann NY Acad Sci

Author:

RICHARDSON K.,COOPER K.,MARRIOTT M. S.,TARBIT M. H.,TROKE P. F.,WHITTLE P. J.

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1988.tb40385.x/fullpdf

Reference3 articles.

1. Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes

2. 2. M. S. Marriott, R. J. Andrews, K. Richardson, P. F. Troke, and J. Ishigami. 1985 . InRecent Advances in Chemotherapy . 1936 -1937 . University of Tokyo Press.

3. Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An updated review on 1,2,3-/1,2,4-triazoles: synthesis and diverse range of biological potential;Molecular Diversity;2024-07-27

2. Asymmetric Synthesis of Triazole Antifungal Agents Enabled by an Upgraded Strategy for the Key Epoxide Intermediate;The Journal of Organic Chemistry;2024-03-21

3. An updated review on diverse range of biological activities of 1,2,4-triazole derivatives: Insight into structure activity relationship;Journal of Molecular Structure;2023-02

4. Applications of piperazine scaffold in drug design;Privileged Scaffolds in Drug Discovery;2023

5. Piperazine‐Modified Ketoconazole Derivatives Show Increased Activity against Fungal and Trypanosomatid Pathogens;ChemMedChem;2022-09-29